LAWRENCE, Mass., July 10, 2017 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical technology company
focused on advancing renal care, today announced plans to release
its financial results for the second quarter ended June 30, 2017, on Wednesday, August 9, 2017, before the opening of
the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, August 9, 2017, to discuss its second
quarter financial results. To listen to the conference call, please
dial 877-392-9886 (domestic) or 707-287-9329 (international). The
call will also be webcast LIVE and can be accessed via the investor
relations section of the Company's website at
http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through August 17, 2017. To access the replay, dial
855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 49508904. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq:
NXTM) is a leading medical technology company, headquartered in
Lawrence, Massachusetts, USA, that
develops, manufactures and markets innovative products for the
treatment of end-stage renal disease (ESRD) and acute kidney
failure. NxStage also has established a small number of dialysis
clinics committed to the development of innovative care delivery
models for patients with ESRD. For more information on NxStage and
its products and services, please visit the Company's websites at
www.nxstage.com and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. The forward-looking
statements in this release include NxStage's plan to release its
financial results on August 9, 2017.
Actual results may differ materially from those indicated by these
forward-looking statements as a result of various important factors
including those that are discussed in NxStage's filings with the
Securities and Exchange Commission, including the Quarterly Report
on Form 10-Q for the quarter ended March 31,
2017. NxStage is under no obligation to (and expressly
disclaims any such obligation to) update or alter its
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/nxstage-to-report-second-quarter-2017-financial-results-300485553.html
SOURCE NxStage Medical, Inc.